Ashridge Business School NHS
European gold award for NHS, Ashridge and National Institute of Health Research
Release date: 18/06/2015
A collaboration between the NHS, Ashridge Business School, and the National Institute of Health Research (NIHR) has been awarded Gold for Organisational Development at the 2015 European Foundation for Management Development (EFMD) Excellence in Practice Awards.
The initiative was designed to facilitate ‘faster and easier’ clinical research in the NHS in England, and to maximise the contribution that research makes to the ‘health and wealth’ of the nation. The process involved 128 NHS Research & Development managers and directors from 64 NHS Trusts.
It has led to impressive levels of impact individually, organisationally, across the whole of the NHS system and the wider world of R&D. The result is improved efficiency, reduced costs and an increase in the growth and scope of research. But, most importantly, it is the patient who will benefit with the ultimate development of new and better treatments, delivered more efficiently and quickly.
Phil Glanfield, Client Director at Ashridge, said: “The commitment of participating research leaders has been outstanding. They have made the most of this opportunity to lead a revolution in performance and culture within and between their Trusts.” The approach was based on a 15-month process thoughtfully designed to ensure that individual and organisation development happened simultaneously.
Dr Russell Hamilton. Director of Research and Development, Department of Health, commented: “This three-way partnership has made an important contribution to the development of an improved quality of clinical research in the NHS, which means faster translation of health research into benefits for patients. So we’re delighted to see that the work has been recognised in this way.”
Professor Charles Wolfe, Director of R&D, NIHR, said: “For us, the Ashridge programme has played an important role in identifying and developing our leadership styles, enabling us to more effectively influence the R&D agenda within our complex local NHS environment.”